No retraction, correction or concern found when last checked on Oct 16, 2026.
Post-stroke infection: A systematic review and meta-analysis
Willeke F Westendorp, Paul J Nederkoorn, Jan-Dirk Vermeij and 2 more
BMC Neurology · 2011 · Meta-analysis
Abstract
Background. stroke is the main cause of disability in high-income countries, and ranks second as a cause of death worldwide. Patients with acute stroke are at risk for infections, but reported post-stroke infection rates vary considerably. We performed a systematic review and meta-analysis to estimate the pooled post-stroke infection rate and its effect on outcome.
Methods. MEDLINE and EMBASE were searched for studies on post-stroke infection. Cohort studies and randomized clinical trials were included when post-stroke infection rate was reported. Rates of infection were pooled after assessment of heterogeneity. Associations between population- and study characteristics and infection rates were quantified. Finally, we reviewed the association between infection and outcome.
Results. 87 studies were included involving 137817 patients. 8 studies were restricted to patients admitted on the intensive care unit (ICU). There was significant heterogeneity between studies (P < 0.001, I2 = 97%). The overall pooled infection rate was 30% (24-36%); rates of pneumonia and urinary tract infection were 10% (95% confidence interval [CI] 9-10%) and 10% (95%CI 9-12%). For ICU studies, these rates were substantially higher with 45% (95% CI 38-52%), 28% (95%CI 18-38%) and 20% (95%CI 0-40%). Rates of pneumonia were higher in studies that specifically evaluated infections and in consecutive studies. Studies including older patients or more females reported higher rates of urinary tract infection. Pneumonia was significantly associated with death (odds ratio 3.62 (95%CI 2.80-4.68).
Conclusions. Infection complicated acute stroke in 30% of patients. Rates of pneumonia and urinary tract infection after stroke were 10%. Pneumonia was associated with death. Our study stresses the need to prevent infections in patients with stroke.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 16, 2026. Paragraph numbers are ours, so an answer can point at one.
Background
Infection is a common complication in the acute phase after stroke. Reported infection rates after stroke vary considerably, ranging 5-65%. Differences in patient populations, study design and definition of infection may account for these large variations in post stroke infection rates. However, a reliable pooled estimate of the infection rate in patients with stroke is lacking. Pneumonia is the most common post-stroke infection and been associated with a relative risk of 3.0 for mortality in a study including 14293 patients with stroke. Consequently, new treatment strategies, i.e. preventive antibiotics, are currently under investigation. In this systematic review and meta-analysis we calculated the pooled post-stroke infection rates, identified study and population characteristics associated with infection, and estimated the impact of pneumonia on outcome after stroke.
Selection of studies
Cohort studies and randomized clinical trials (RCT) on ischemic or hemorrhagic stroke with reported rates of infections in the acute phase were included. In- and exclusion criteria are listed in Additional File 1: Table S1. A literature search in MEDLINE (1950 to present) and EMBASE (1980 to present) was performed without language restrictions (Additional File 1: Table S2). Cross references were checked and experts in the field were consulted. Infection was defined according to the criteria used in included studies. Studies including a small subgroup of patients, i.e., those restricted to patients with dysphagia, were excluded to minimize selection bias. If two publications described one similar patient group data was used only once; this occurred three times. If studies reported data of different treatment arms separately, these were also included as separate groups in our analysis. Treatment arms in randomized controlled trials on preventive antibiotic therapy were excluded, since this is likely to influence infection rate and is not part of standard stroke care.
Data extraction
Two independent observers (WFW and JDV) extracted data from selected articles according to predefined definitions. Disagreement was resolved by discussion.
Overall infection rate and rate of pneumonia and urinary tract infection - the most common post-stroke infections - were extracted. When percentages were given, these were converted into absolute numbers. We did not calculate an overall infection rate in each study by adding data on different infections, because of the possibility of two infections occurring in one patient.
We also extracted the study characteristics prospective design, consecutive enrollment, type of stroke, study aim on infection and observation period. Population characteristics extracted were income country, age, gender, ICU study, infarction or bleeding, stroke severity, lowered consciousness, dysphagia and urinary incontinence/retention. Definitions can be found in Additional File 1: Table S3.
Analyses
For each study we calculated the proportion of overall infection, pneumonia and urinary tract infection. Next, these proportions were pooled using Review Manager to obtain one estimate for each infection. A fixed or random effects model was chosen after tests of heterogeneity (heterogeneity was defined with p-value < 0.05). Subgroup analysis was performed on Intensive Care Unit (ICU) vs. non-ICU studies. Subsequently, we performed univariate analyses investigating the association between population and study characteristics and the pooled proportion of infection, pneumonia and urinary tract infection. Pearson or Spearman correlation, Students T-Test, Mann-Whitney U Test or 1-way ANOVA were used when appropriate. Characteristics with a p-value < 0.10 were included in a multivariate regression analysis. To transform the proportion of pneumonia and urinary tract infection in a normally distributed variable we used arc sin-square root and square root transformations. Review Manager 5 and SPSS (version 16.0) were used for the statistical analyses.
Included studies
Figure 1 summarizes the study selection process. 87 studies were included involving 137817 patients. 8 studies included patients admitted on the ICU and 79 studies included patients admitted on stroke-unit, medium care facility or ward (non-ICU studies). Reasons for exclusion are noted in Additional File 1: Table S4. Not all characteristics could be extracted from all studies: age was reported in 77 studies; gender in 80; observation period in 73; stroke severity in 21; lowered consciousness in 25; urinary incontinence/retention in 6; and dysphagia in 26 studies. All extracted data is shown Additional File 2: Table S1.
Pooled infection rates
Infection rates were evaluated in all 87 studies (Table 1). Pooled values were calculated in a random effects model because of significant heterogeneity between studies (P < 0.001, I2 = 97%). The overall pooled infection rate was 30% (95%CI 24-36%). The pooled pneumonia rate was 10% (95%CI 9-10%) and of urinary tract infection 10% (95%CI 9-12%). In ICU studies, overall infection rate was 45% (95%CI 38-52%) and rates of pneumonia and urinary tract infection were 28% (95%CI 18-38%) and 20% (95%CI 0-40%). In non-ICU studies, overall infection rate was 28% (95%CI 22-34%) and rates of pneumonia and urinary tract infection were 9% (95%CI 9-10%) and 10% (95%CI 8-11%).
Associations with population- and study characteristics
Associations between population and study characteristics with infection rates are noted in Table 2 and 3. In univariate analysis, infection rate was higher in ICU-studies (P = 0.05) and in studies with a longer observation period (P = 0.03); a trend towards significance was seen for lowered consciousness (P = 0.06). We did not perform multivariate analysis for infection, because few studies reported all 3 variables. In the subgroup of non-ICU studies, an even stronger association was seen for observation period (P = 0.003).
The rate of pneumonia was higher in ICU studies (P = 0.001), prospective studies (P = 0.02), studies that specifically evaluated infections (P = 0.004), studies with consecutive enrollment (P = 0.005), studies with a higher stroke severity (P = 0.01) and studies with higher proportions of patients with a lowered consciousness (P = 0.001). Stroke severity was closely related to ICU-study (Mann-Whitney U, Z -2,154, P = 0.02). In multivariate analysis pneumonia rate was associated with study characteristics: ICU studies (B 0.207, standard error (se) 0.042, P <0.01), study aim on infection (B 0.062, se 0.026, P = 0.02), consecutive enrollment (B 0.058, se 0.024, P = 0.02). Stroke severity and lowered consciousness were excluded from this multivariate analysis since these characteristics were only reported in a relatively small number of studies. In non-ICU studies, rate of pneumonia was also higher in studies that specifically evaluated infections (B 0.06, se 0.025, P = 0.02) and studies with consecutive enrollment (B 0.065, se 0.022, P = 0.005) in multivariate analysis. No associations were found between age (P = 0.18) or dysphagia (P = 0.16) and pneumonia rate.
The rate of urinary tract infections was higher in studies with a higher stroke severity (P = 0.01), a lower proportion of male patients (P = 0.005), prospective studies (P = 0.02) and in studies with a longer observation period (P = 0.10). A trend towards significance was seen for studies with a higher mean age (P = 0.08). In multivariate analysis, advanced age was independently associated with urinary tract infection (B 0.008, se 0.004, P = 0.04). Gender was associated with urinary tract infection, but only in a sub analysis of non-ICU studies (B -0,341, se 0.164, P = 0.04).
Outcome
To estimate the effect of post-stroke infection on outcome we pooled the mortality rates in patients with and without infection of the studies reporting these rates. Of all patients with an infection, 48% died vs. 18% of patients without infection (N = 1839; OR 2.08, 95% CI 1.63 - 2.67). Mortality rates were also higher in patients with pneumonia (26% vs. 5%, N = 16433; OR 5.58, 95% CI 4.76, 6.55) and a little higher in patients with urinary tract infection (12% vs. 10%, N = 2528; OR 1.12, 95% CI 0.76, 1.66). Since this data was not corrected for potential confounders, we also estimated the effect of pneumonia on death by pooling corrected odds ratios (OR) in a random effects model. This meta-analysis included four studies (19971 patients) and resulted in an OR in-hospital mortality of 3.62 (95% CI 2.80-4.68) (Figure 2). Five studies reported corrected OR of pneumonia for unfavorable outcome (Table 4); meta-analysis was not performed because of differences in outcome measure and follow-up. These studies showed an increased risk of unfavorable outcome in post-stroke patients with pneumonia. Urinary tract infection had no association with death according to four studies reporting on this. Three studies evaluated the effect on functional outcome for urinary tract infection, two studies showed an association with poor outcome in multivariate analysis. OR's for unfavorable functional outcome were 2.72 (95% CI 4.73-11.84) and 3.1 (95% CI 1.6-5.9).
Discussion
This meta-analysis shows that infections commonly complicate the acute phase after stroke. The pooled overall infection rate was 30% and pneumonia and urinary tract infections occurred each in 10% of patients. Previous studies showed a wide range of post-stroke infection rates, from 5%- 65% for infections, 1%-33% for pneumonia, and 2%-27% for urinary tract infection. This meta-analysis included a large number of patients and therefore provides a reliable estimate of infection after stroke.
We identified several study and population characteristics that were associated with infection rate. Given the prevalence of pneumonia and urinary tract infection in general wards in Dutch hospitals - 1.1% and 1.7% respectively - our findings confirm that infection rate in patients in the acute phase of stroke is high. This increased vulnerability of patients in the acute phase of stroke for infections can be attributed to different factors.
First, infection was associated with study characteristics. Studies aimed on infection and those with consecutive enrolment were associated with higher infection rate. Possibly, these studies benefit of more rigorous detection of infection. Rate of infection was also higher in studies with a longer observation time. In a prospective observational study, most post stroke infections occurred within three days of hospital admission. Nevertheless, 25% of infections occurred after these three days. Also, most urinary tract infections occur after 48 hours, i.e. most UTI's are hospital acquired, and therefore it seems logical that a longer observation time yielded a higher urinary tract infection rate in our study. The absence of an association between observation time and pneumonia is not surprising. Pneumonia is mostly diagnosed within the first days following a stroke, both in studies performed on general wards as well as ICU's.
Microbiologic data of patients with post-stroke pneumonia shows a pattern of mostly early onset nosocomial pneumonia, or a community acquired aspiration syndrome. Staphylococcus aureus and gram-negative bacteria such as Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli or Enterobacter spp. were commonly identified; also Streptococcus species are occasionally found. Gram-negative bacteria and Staphylococcus aureus are known to cause pneumonia by aspiration of endogenous material from the colonized oropharynx. These pathogens are often seen in nosocomial infections. Streptococcus species is still the most detected pathogen in community acquired pneumonia. In stroke patients, it could be a cause of 'community acquired aspiration pneumonia', with aspiration occurring at the stroke ictus. Often, no causative organism is detected in post-stroke pneumonia. Yield of cultures is usually not very high in patients with pneumonia; collection of material could be even more difficult in stroke patients due to neurologic deficit or lowered level of consciousness. Also, some cases of suspected pneumonia could in fact be a non-infectious aspiration pneumonitis, or the infection could be caused by anaerobic bacteria that require special culturing techniques. However, the role of anaerobic bacteria in the development of pneumonia is unclear.
Second, infection rate was associated with the patients' clinical condition. Studies including patients with a higher stroke severity or lower levels of consciousness showed higher infection rates, in particular for pneumonia. This effect corresponds with previous studies that often report both characteristics as risk factors for pneumonia. Risk for aspiration is increased in these patients due to the absence of protective reflexes, and this risk is related to the degree of consciousness impairment. Most stroke related pneumonias are believed to result from dysphagia and subsequent aspiration of oropharyngeal material or gastric content. A systematic review by Martino et al showed that dysphagia occurs in 37- 78% of stroke patients and increases the risk for pneumonia 3-fold and 11-fold in patients with confirmed aspiration. However, up to half of patients with post stroke pneumonia do not aspirate, which implies that also other mechanisms are involved, e.g., stroke-induced immunodepression which is discussed below.
We also found higher infection rates in ICU studies. Patients admitted to an ICU generally suffer from more severe strokes and also the frequency of invasive procedures is higher. The use of invasive procedures - i.e. urinary catheterization or mechanical ventilation in ICU patients - increase infection risk by facilitating the entry of a pathogen.
We identified a higher age and female sex as risk factors for urinary tract infection. Both of these characteristics have previously been reported as risk factors for urinary tract infection. Studies frequently report urinary catheterization as an important risk factor; we could not investigate this association because this characteristic was mostly not reported. Advanced age as risk factor for post-stroke infection has been reported previously.
In addition to above mentioned characteristics, acute stroke may lead to stroke-induced immunodepression, a systemic anti-inflammatory response that is related to susceptibility to infection. This anti-inflammatory response was found in different clinical studies in acute stroke patients, and includes an excessive counter-inflammatory cytokine responses and impairments in cell-mediated immunity. Certain features of this response - i.e., reduced lymphocyte count, delay in the recovery of T-lymphocyte loss - were more pronounced in patients developing post stroke infections. These results suggest that immunological changes could facilitate infection in acute stroke.
Outcome is affected by post-stroke infections, as shown in our review. Pneumonia and urinary tract infection both increase the risk for unfavorable outcome and pneumonia is associated with mortality with an OR of 3.62. Infections could affect outcome in several ways. Firstly, they lead to immobilization, general frailty and a delay in rehabilitation due to prolonged hospital stay. More importantly, immunological effects of infections could worsen outcome. Evidence from experimental studies suggests that infection promotes antigen presentation and autoimmunity against the brain. However, the evidence on this topic is scarce and the exact pathofysiology remains to be investigated.
Our systematic review has limitations. First, results are limited by publication bias. Data was derived from randomized controlled trials, cohort studies and stroke registries; infection rate could differ in hospitals without stroke research or complication registries. Second, included studies were heterogeneous in definition of infection, which was based on clinical grounds and in some cases not described. A standardized definition for infection - as described by the Centers for Disease Control and Prevention - is preferred since stricter criteria could permit identification of fewer infections. Next, not all relevant characteristics - for example use of antibiotics, differences in primary stroke care or use of a urinary catheter - could be evaluated, due to lack of data in included studies. Some of these characteristics have previously been described as a risk factor for infection and could have confounded our results. Thirdly, for some characteristics data was lacking in many studies. Surprisingly, no association was found between age or dysphagia and pneumonia rate, often described risk factors for pneumonia. Dysphagia was not reported in all studies, which was a limiting factor in the analysis. Lack of these significant associations could be due to few studies reporting adequate information on all these characteristics and therefore the analyses have low explanatory power. Finally, many of the characteristics act on patient level, but studies report aggregate data (i.e., mean age of study population) also reducing explanatory power. Due to these limitations - most importantly the heterogeneity in definition of infections - results of this review need to be interpreted with caution.
Our review shows the potential of strategies aiming to prevent infections in patients with stroke. Some of these strategies - i.e., prevention of aspiration and reduction of urinary catheterisation - are incorporated in stroke unit care, which reduces the risk of death after stroke through the prevention of infections in particular. Infections can also be prevented by use of preventive antibiotic therapy, as shown in a recent meta-analysis. This meta-analysis did not establish a reduction in mortality, however, included studies were small and heterogeneous and functional outcome was not evaluated. Also, limited data was reported on the effect on antibiotic resistance. Currently, the use of preventive antibiotics in stroke, and the effect of this therapy on antibiotic resistance, is investigated in a large randomized controlled trial with functional endpoint. This trial will be able to establish whether preventive antibiotic treatment is an effective strategy to prevent infection and its adverse effect on outcome in patients in the acute phase of stroke.
Conclusions
Results of this meta-analysis show an overall infection rate in the acute phase of stroke of 30%. Rates of pneumonia and urinary tract infection were both 10%. Infection rates are related with study characteristics and the patients' clinical condition, e.g., age, gender, stroke severity, level of consciousness and whether a patient is admitted on ICU. Pneumonia is an independent risk factor for unfavorable outcome and death after stroke. Our data stress the need of interventions to prevent infections in patients with stroke.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
WFW participated in the conceptualization and design of the review, performed the selection of studies, data-extraction and -analysis, and drafted the review. PJN and DvdB were involved in the conceptualization and design of the review, and the data analysis. JDV participated in the selection of studies and data-extraction. MGD carried out the statistical analysis and interpretation of data. All authors participated in revising the manuscript and the final approval of the manuscript.
Sources of funding
This work was supported by the Netherlands Organisation for Health Research and Development (ZonMW): 171002302 and the Netherlands Heart Foundation (Hartstichting): 2009B095. DvdB is supported by grants from the Netherlands Organization for Health Research and Development (ZonMw; NWOVeni grant 2006 [916.76.023], NWO-Vidi grant 2010 [016.116.358]) and the Academic Medical Center (AMC Fellowship 2008).
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2377/11/110/prepub
References 46
- 1.
Vermeij FH Scholte op Reimer WJ de Man MP van Oostenbrugge RJ Franke CL de Jong G de Kort PL Dippel DW Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke SurveyCerebrovasc Dis2009 27465471
Not in our library10.1159/000210093
- 2.
Katzan IL Cebul RD Husak SH Dawson NV Baker DW The effect of pneumonia on mortality among patients hospitalized for acute strokeNeurology2003 60620625
Not in our library10.1212/01.wnl.0000046586.38284.60
- 3.
Nederkoorn PJ Westendorp WF Hooijenga IJ de Haan RJ Dippel DW Vermeij FH Dijkgraaf MG Prins JM Spanjaard L van de Beek D Preventive antibiotics in stroke study: rationale and protocol for a randomised trialInt J Stroke2011 6159163
Not in our library10.1111/j.1747-4949.2010.00555.x
- 4.
Dziedzic T Pera J Klimkowicz A Turaj W Slowik A Rog TM Szczudlik A Serum albumin level and nosocomial pneumonia in stroke patientsEur J Neurol2006 13299301
Not in our library10.1111/j.1468-1331.2006.01210.x
- 5.
Dziedzic T Slowik A Pera J Szczudlik A Beta-blockers reduce the risk of early death in ischemic strokeJ Neurol Sci2007 2525356
Not in our library10.1016/j.jns.2006.10.007
- 6.
Lees KR Zivin JA Ashwood T Davalos A Davis SM Diener HC Grotta J Lyden P Shuaib A Hardemark HG Wasiewski WW NXY-059 for acute ischemic strokeN Engl J Med2006 354588600
Not in our library10.1056/nejmoa052980
- 7.
Schwab S Schwarz S Bertram M Spranger M Hacke W [Moderate hypothermia for the treatment of malignant middle cerebral artery infarct]Nervenarzt1999 70539546
Not in our library10.1007/s001150050477
- 8.
Schwab S Georgiadis D Berrouschot J Schellinger PD Graffagnino C Mayer SA Feasibility and safety of moderate hypothermia after massive hemispheric infarctionStroke2001 3220332035
Not in our library10.1161/hs0901.095394
- 9.
Shuaib A Lees KR Lyden P Grotta J Davalos A Davis SM Diener HC Ashwood T Wasiewski WW Emeribe U NXY-059 for the treatment of acute ischemic strokeN Engl J Med2007 357562571
Not in our library10.1056/nejmoa070240
- 10.
Newell SD Englert J Box-Taylor A Davis KM Koch KE Clinical efficiency tools improve stroke management in a rural southern health systemStroke1998 2910921098
Not in our library10.1161/01.str.29.6.1092
- 11.
Webb DJ Fayad PB Wilbur C Thomas A Brass LM Effects of a specialized team on stroke care. The first two years of the Yale Stroke ProgramStroke1995 2613531357
Not in our library10.1161/01.str.26.8.1353
- 12.
van de Beek D Wijdicks EF Vermeij FH de Haan RJ Prins JM Spanjaard L Dippel DW Nederkoorn PJ Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysisArch Neurol2009 6610761081
Not in our library10.1001/archneurol.2009.176
- 13.
Davenport RJ Dennis MS Wellwood I Warlow CP Complications After Acute StrokeStroke1996 27415420
Not in our library10.1161/01.str.27.3.415
- 14.
Aslanyan S Weir CJ Diener HC Kaste M Lees KR Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trialEur J Neurol2004 114953
Not in our library10.1046/j.1468-1331.2003.00749.x
- 15.
- 16.
Ovbiagele B Hills NK Saver JL Johnston SC Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalizationJ Stroke Cerebrovasc Dis2006 15209213
Not in our library10.1016/j.jstrokecerebrovasdis.2006.05.004
- 17.
Stott DJ Falconer A Miller H Tilston JC Langhorne P Urinary tract infection after strokeQJM2009 102243249
Not in our library10.1093/qjmed/hcp012
- 18.
Hong KS Kang DW Koo JS Yu KH Han MK Cho YJ Park JM Bae HJ Lee BC Impact of neurological and medical complications on 3-month outcomes in acute ischaemic strokeEur J Neurol2008 1513241331
Not in our library10.1111/j.1468-1331.2008.02310.x
- 19.
Pinto AN Melo TP Lourenco ME Leandro MJ Brazio A Carvalho L Franco AS Ferro JM Can a clinical classification of stroke predict complications and treatments during hospitalization?Cerebrovasc Dis1998 8204209
Not in our library10.1159/000015852
- 20.
Emsley HC Hopkins SJ Acute ischaemic stroke and infection: recent and emerging conceptsLancet Neurol2008 7341353
Not in our library10.1016/s1474-4422(08)70061-9
- 21.
van der Kooi TI Mannien J Wille JC van Benthem BH Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studiesJ Hosp Infect2010 75168172
Not in our library10.1016/j.jhin.2009.11.020
- 22.
Georgilis K Plomaritoglou A Dafni U Bassiakos Y Vemmos K Aetiology of fever in patients with acute strokeJ Intern Med1999 246203209
Not in our library10.1046/j.1365-2796.1999.00539.x
- 23.
Hassan A Khealani BA Shafqat S Aslam M Salahuddin N Syed NA Baig SM Wasay M Stroke-associated pneumonia: microbiological data and outcomeSingapore Med J2006 47204207
Not in our library
- 24.
Hilker R Poetter C Findeisen N Sobesky J Jacobs A Neveling M Heiss WD Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicineStroke2003 34975981
Not in our library10.1161/01.str.0000063373.70993.cd
- 25.
Gosney M Martin MV Wright AE The role of selective decontamination of the digestive tract in acute strokeAge Ageing2006 354247
Not in our library10.1093/ageing/afj019
- 26.
Millns B Gosney M Jack CI Martin MV Wright AE Acute stroke predisposes to oral gram-negative bacilli -- a cause of aspiration pneumonia?Gerontology2003 49173176
Not in our library10.1159/000069171
- 27.
Jones RN Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumoniaClin Infect Dis2010 51Suppl 1S81S87
Not in our library10.1086/653053
- 28.
Bartlett JG Community-acquired pneumoniaInt J Clin Pract Suppl2000 1822
Not in our library
- 29.
Marik PE Aspiration pneumonitis and aspiration pneumoniaN Engl J Med2001 344665671
Not in our library10.1056/nejm200103013440908
- 30.
Marik PE Careau P The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective studyChest1999 115178183
Not in our library10.1378/chest.115.1.178
- 31.
Hinchey JA Shephard T Furie K Smith D Wang D Tonn S Formal dysphagia screening protocols prevent pneumoniaStroke2005 3619721976
Not in our library10.1161/01.str.0000177529.86868.8d
- 32.
Kwon HM Jeong SW Lee SH Yoon BW The pneumonia score: a simple grading scale for prediction of pneumonia after acute strokeAm J Infect Control2006 346468
Not in our library10.1016/j.ajic.2005.06.011
- 33.
Adnet F Baud F Relation between Glasgow Coma Scale and aspiration pneumoniaLancet1996 348123124
Not in our library10.1016/s0140-6736(05)64630-2
- 34.
Martino R Foley N Bhogal S Diamant N Speechley M Teasell R Dysphagia after stroke: incidence, diagnosis, and pulmonary complicationsStroke2005 3627562763
Not in our library10.1161/01.str.0000190056.76543.eb
- 35.
Walter U Knoblich R Steinhagen V Donat M Benecke R Kloth A Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unitJ Neurol2007 25413231329
Not in our library10.1007/s00415-007-0520-0
- 36.
Chamorro A Amaro S Vargas M Obach V Cervera A Torres F Planas AM Interleukin 10, monocytes and increased risk of early infection in ischaemic strokeJ Neurol Neurosurg Psychiatry2006 7712791281
Not in our library10.1136/jnnp.2006.100800
- 37.
Haeusler KG Schmidt WU Fohring F Meisel C Helms T Jungehulsing GJ Nolte CH Schmolke K Wegner B Meisel A Dirnagl U Villringer A Volk HD Cellular immunodepression preceding infectious complications after acute ischemic stroke in humansCerebrovasc Dis2008 255058
Not in our library10.1159/000111499
- 38.
Emsley HC Smith CJ Hopkins SJ Infection and brain-induced immunodepression after acute ischemic strokeStroke2008 39e7
Not in our library10.1161/strokeaha.107.500447
- 39.
Vogelgesang A Grunwald U Langner S Jack R Broker BM Kessler C Dressel A Analysis of lymphocyte subsets in patients with stroke and their influence on infection after strokeStroke2008 39237241
Not in our library10.1161/strokeaha.107.493635
- 40.
Spratt N Wang Y Levi C Ng K Evans M Fisher J A prospective study of predictors of prolonged hospital stay and disability after strokeJ Clin Neurosci2003 10665669
Not in our library10.1016/j.jocn.2002.12.001
Cited by papers we hold 9
- Sepsis in Patients With Large Vessel Occlusion Stroke–Clinical Characteristics and Outcome · 2022Not checked
- Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation · 2022No notice
- Systemic inflammation after stroke: implications for post‐stroke comorbidities · 2022No notice
- Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections · 2021No notice
- External validation of the A2DS2 and ISAN scales for predicting infectious respiratory complications of ischaemic stroke · 2019Not checked
- Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. · 2018Not checked
- Stroke in the 2 1 s t Century: A Snapshot of the Burden, Epidemiology, and Quality of Life · 2018No notice
- The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments) · 2017No notice
- Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications · 2016No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.